| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Sep―25 |
Impact of COVID-19 on Precocious Puberty: A Meta-Analysis and Its Relevance to Philippine Pediatric Health |
John Patrick Toledo |
| 2 |
[GO] |
2024―Sep―18 |
COVID-19 Mortality in Kentucky by Age and Race: Simpson’s Paradox |
Steven Auche, Claire Holiday, Kathleen Winter, Douglas Thoroughman, Kevin B Spicer |
| 3 |
[GO] |
2024―Sep―10 |
Refining Estimation of the Instantaneous Reproduction Number During Early Pandemic Stages: Addressing Case-Reporting Variability and Serial Interval Uncertainty |
Gary Hettinger, David Rubin, Jing Huang |
| 4 |
[GO] |
2024―Sep―02 |
Reduced Risk of SARS-CoV-2 Infection Among Household Contacts with Recent Vaccination and Past COVID-19 Infection: Results from Two Multi-Site Case-Ascertained Household Transmission Studies |
Melissa A Rolfes, H Keipp Talbot, Kerry Grace Morrissey, Melissa S Stockwell, Yvonne Maldonado, Huong Q McLean, et al. (+38) Karen Lutrick, Natalie M Bowman, Suchitra Rao, Hector S Izurieta, Yuwei Zhu, James Chappell, Steph Battan-Wraith, Lori S Merrill, Son McClaren, Ellen Sano, Joshua G Petrie, Jessica Biddle, Sheroi Johnson, Philip Salvatore, Sarah E Smith-Jeffcoat, Edwin J Asturias, Jessica T Lin, Katherine D Ellingson, Edward A Belongia, Vanessa Olivo, Alexandra M Mellis, Carlos G Grijalva, Carrie Reed, Jonathan Schmitz, Kimberly Hart, Clea Sarnquist, Sara Goodman, Prasanthi Govindaranjan, Karla Ledezma, Kathleen Pryor, Ayla Bullock, Amy Yang, Quenla Haehnel, Julienne Reynolds, Katherine Murray, Miriana Moreno, Ana Valdez de Romero, Celibell Vargas |
| 5 |
[GO] |
2024―Sep―02 |
U.S. County-level Food Insecurity and COVID-19 Mortality: A Bayesian Spatial Analysis with R-INLA |
Christian A Maino Vieytes, Mauricio Campos, Sara L McLafferty, May A Beydoun, Francesca Gany, Anna E Arthur, Rebecca L Smith |
| 6 |
[GO] |
2024―Aug―29 |
Tracking vaccine effectiveness in an evolving pandemic, countering misleading hot takes and epidemiological fallacies |
Jeffrey S Morris |
| 7 |
[GO] |
2024―Aug―27 |
Applying a Bayesian Spatiotemporal Model to Examine Excess County-Level Cardiovascular Disease Death Rates During the COVID-19 Pandemic |
Adam S Vaughan, Harrison Quick, Kara B Beck, Rebecca C Woodruff, David DeLara, Michele Casper |
| 8 |
[GO] |
2024―Aug―22 |
Risk of COVID-19 Reinfection and Vaccine Breakthrough Infection, Madera County, California, 2021 |
Minhphuong Nguyen, Eric Paul, Paul K Mills, Simon Paul |
| 9 |
[GO] |
2024―Aug―09 |
The mediating role of SARS-CoV-2 variants between income and hospitalisation due to COVID-19: A period-based mediation analysis |
Sean P Harrigan, Chad D Fibke, Héctor A Velásquez García, Sunny Mak, James Wilton, Natalie Prystajecky, et al. (+7) John Tyson, Linwei Wang, Beate Sander, Stefan Baral, Sharmistha Mishra, Naveed Z Janjua, Hind Sbihi |
| 10 |
[GO] |
2024―Aug―08 |
Generalized anxiety disorder in low-resourced adults: a nationally representative, longitudinal cohort study across the COVID-19 pandemic |
Catherine K Ettman, Salma M Abdalla, Ruochen Wang, Samuel B Rosenberg, Sandro Galea |
| 11 |
[GO] |
2024―Jul―17 |
Insights into COVID-19 epidemiology and control from temporal changes in serial interval distributions in Hong Kong |
Sheikh Taslim Ali, Dongxuan Chen, Yiu-Chung Lau, Wey Wen Lim, Amy Yeung, Dillon C Adam, et al. (+11) Eric H Y Lau, Jessica Y Wong, Jingyi Xiao, Faith Ho, Huizhi Gao, Lin Wang, Xiao-Ke Xu, Zhanwei Du, Peng Wu, Gabriel M Leung, Benjamin J Cowling |
| 12 |
[GO] |
2024―Jul―16 |
Barriers to initial COVID-19 booster among U.S. adults who completed a primary vaccine series in the CHASING COVID cohort, September 2021 - October 2022 |
Madhura S Rane, Yanhan Shen, Mc Kaylee Robertson, Kate Penrose, Avantika Srivastava, Laura Puzniak, et al. (+9) Kristen E Allen, Thomas M Porter, Sarah Kulkarni, William You, Amanda Berry, Angela M Parcesepe, Christian Grov, Rebecca Zimba, Denis Nash |
| 13 |
[GO] |
2024―Jul―05 |
Assessing the Quality of Cause-of-Death Reporting Before and During the COVID-19 Pandemic |
Shu-Yu Tai, Ichiro Kawachi, Tsung-Hsueh Lu |
| 14 |
[GO] |
2024―Jul―04 |
A causal machine-learning framework for studying policy impact on air pollution: A case-study in COVID-19 lockdowns |
Claire Heffernan, Kirsten Koehler, Misti Levy Zamora, Colby Buehler, Drew R Gentner, Roger D Peng, Abhirup Datta |
| 15 |
[GO] |
2024―Jul―04 |
Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example |
Sophie H Bots, Svetlana Belitser, Rolf H H Groenwold, Carlos E Durán, Judit Riera-Arnau, Anna Schultze, et al. (+17) Davide Messina, Elena Segundo, Ian Douglas, Juan José Carreras, Patricia Garcia-Poza, Rosa Gini, Consuelo Huerta, Mar Martín-Pérez, Ivonne Martin, Olga Paoletti, Carlo Alberto Bissacco, Elisa Correcher-Martínez, Patrick Souverein, Arantxa Urchuequía, Felipe Villalobos, Miriam C J M Sturkenboom, Olaf H Klungel |
| 16 |
[GO] |
2024―Jul―03 |
Death on the permafrost: Revisiting the 1918-20 influenza pandemic in Alaska using death certificates |
Lisa Sattenspiel, Svenn-Erik Mamelund, Sushma Dahal, Amanda Wissler, Gerardo Chowell, Emma Tinker-Fortel |
| 17 |
[GO] |
2024―Jun―21 |
A Propensity Score Approach and a Partitioned Approach for the Self-Controlled Case Series Design to Evaluate Safety of a 2-dose Vaccine Series: Application to myocarditis/pericarditis following mRNA COVID-19 vaccination |
Stanley Xu, Lina S Sy, Bing Han, Vennis Hong, Katia J Bruxvoort, Bruno Lewin, et al. (+2) Kimberly J Holmquist, Lei Qian |
| 18 |
[GO] |
2024―Jun―18 |
Prior infections and effectiveness of SARS-CoV-2 vaccine in test-negative studies: A systematic review and meta-analysis |
Tim K Tsang, Sheena G Sullivan, Xiaotong Huang, Can Wang, Yifan Wang, Joshua Nealon, et al. (+3) Bingyi Yang, Kylie E C Ainslie, Benjamin J Cowling |
| 19 |
[GO] |
2024―Jun―15 |
The pandemic preterm paradox: A test of competing explanations |
Ralph A Catalano, Tim A Bruckner, Alison Gemmill, Claire E Margerison |
| 20 |
[GO] |
2024―Jun―14 |
SARS-CoV-2 incidence, seroprevalence, and antibody dynamics in a rural, population-based cohort: March 2020 - July 2022 |
Joshua G Petrie, David Pattinson, Jennifer P King, Gabriele Neumann, Lizheng Guan, Peter Jester, et al. (+6) Melissa A Rolfes, Jennifer K Meece, Burney A Kieke, Edward A Belongia, Yoshihiro Kawaoka, Huong Q Nguyen |
| 21 |
[GO] |
2024―May―29 |
Detecting changes in population trends in infection surveillance using community SARS-CoV-2 prevalence as an exemplar |
Emma Pritchard, Karina-Doris Vihta, David W Eyre, Susan Hopkins, Tim E A Peto, Philippa C Matthews, et al. (+7) Nicole Stoesser, Ruth Studley, Emma Rourke, Ian Diamond, Koen B Pouwels, Ann Sarah Walker, the COVID-19 Infection Survey Team |
| 22 |
[GO] |
2024―May―22 |
The role and limitations of electronic medical records versus patient interviews for determining symptoms, underlying comorbidities, and medication usage for patients with COVID-19 |
Raymond A Soto, Grace M Vahey, Kristen E Marshall, Emily McDonald, Rachel Herlihy, Helen M Chun, et al. (+7) Marie E Killerby, Breanna Kawasaki, Claire M Midgley, Nisha B Alden, Jacqueline E Tate, J Erin Staples, Colorado Investigation Team |
| 23 |
[GO] |
2024―May―22 |
Human Epidemiology and RespOnse to SARS-CoV-2 (HEROS): Objectives, Design and Enrollment Results of a 12-City Remote Observational Surveillance Study of Households with Children using Direct-to-Participant Methods |
Patricia C Fulkerson, Stephanie J Lussier, Casper G Bendixsen, Sharon M Castina, Tebeb Gebretsadik, Jessica S Marlin, et al. (+32) Patty B Russell, Max A Seibold, Jamie L Everman, Camille M Moore, Brittney M Snyder, Kathy Thompson, George S Tregoning, Stephanie Wellford, Samuel J Arbes, Leonard B Bacharier, Agustin Calatroni, Carlos A Camargo Jr, William D Dupont, Glenn T Furuta, Rebecca S Gruchalla, Ruchi S Gupta, Gurjit Khurana Hershey, Daniel J Jackson, Christine C Johnson, Meyer Kattan, Andrew H Liu, Liza Murrison, George T O’Connor, Wanda Phipatanakul, Katherine Rivera-Spoljaric, Marc E Rothenberg, Christine M Seroogy, Stephen J Teach, Edward M Zoratti, Alkis Togias, Tina V Hartert, on behalf of the HEROS study team |
| 24 |
[GO] |
2024―May―16 |
Current use of estrogen-containing oral contraceptives or hormone therapy and risk of COVID-19 infection and hospitalization: a population-based cohort study |
Laura B Harrington, J David Powers, Elizabeth A Bayliss, Stephen P Fortmann, Susan M Shortreed, Rod L Walker, et al. (+7) James S Floyd, Jennifer Kuntz, Sharon Fuller, Ladia Albertson-Junkans, Mi H Lee, Lisa A Temposky, Sascha Dublin |
| 25 |
[GO] |
2024―May―14 |
COVID-19 Pandemic Exacerbated Socioeconomic Disparities in Motor Vehicle Traffic Fatalities |
Brian C Tefft, Rebecca Steinbach |
| 26 |
[GO] |
2024―May―14 |
Correction to “Postacute symptoms 4 months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study” |
|
| 27 |
[GO] |
2024―Mar―18 |
Avoidance of care: how health-care affordability influenced COVID-19 disease severity and outcomes |
Chinyere J Okpara, Jasmin Divers, Megan Winner |
| 28 |
[GO] |
2024―Mar―18 |
Re: “Postacute symptoms 4 months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study” |
Bronner P Gonçalves |
| 29 |
[GO] |
2024―Feb―29 |
Missing data and missed infections: Investigating racial and ethnic disparities in SARS-CoV-2 testing and infection rates in Holyoke, Massachusetts |
Sara M Sauer, Isabel R Fulcher, Wilfredo R Matias, Ryan Paxton, Ahmed Elnaiem, Sean Gonsalves, et al. (+4) Jack Zhu, Yodeline Guillaume, Molly Franke, Louise C Ivers |
| 30 |
[GO] |
2024―Feb―20 |
Understanding racial/ethnic disparities in COVID-19 mortality using a novel metric: COVID excess mortality percentage |
Andy Ye Yuan, Vladimir Atanasov, Natalia Barreto, Lorenzo Franchi, Jeff Whittle, Benjamin Weston, et al. (+3) John Meurer, Qian (Eric) Luo, Bernard Black |
| 31 |
[GO] |
2023―Dec―23 |
Life Expectancy among Native Americans during the COVID-19 Pandemic: Estimates, Uncertainty and Obstacles |
Noreen Goldman, Sung S Park, Hiram Beltrán-Sánchez |
| 32 |
[GO] |
2023―Dec―12 |
Revisiting a risk benefit analysis of mRNA COVID-19 vaccines during the omicron era |
Raphael Lataster |
| 33 |
[GO] |
2023―Dec―07 |
RE: “Risk and benefit OF mRNA COVID-19 vaccines for the omicron variant by age, sex, and presence of comorbidity: a quality-adjusted life years analysis” |
Makoto Shiraishi, Masakazu Kurita, Kou Fujisawa, Mutsumi Okazaki |
| 34 |
[GO] |
2023―Nov―15 |
The Landscape of NIAID-funded Observational COVID-19 Cohort Studies |
Reed S Shabman, Mason Booth, Michael Cooper, Marciela M DeGrace, Patricia C Fulkerson, Teresa Hauguel, et al. (+10) Chelsea Lane, Alyssa Meyer, Lori Newman, Diane Post, Mercy Prabhudas, Rubya Qidwai, Cynthia Rojas, Claire Schuster, Carolyn Williams, Liliana Brown |
| 35 |
[GO] |
2023―Nov―15 |
Post-acute symptoms 4 months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study |
Lampros Spiliopoulos, Anna Irene Vedel Sørensen, Peter Bager, Nete Munk Nielsen, Jørgen Vinsløv Hansen, Anders Koch, et al. (+4) Inger Kristine Meder, Poul Videbech, Steen Ethelberg, Anders Hviid |
| 36 |
[GO] |
2023―Nov―15 |
Anti-COVID-19 measures and lifestyle changes during theCOVID-19 pandemic and sleep patterns in the Netherlands: a longitudinal study |
Nekane Sandoval-Diez, Lidwien A M Smit, Jolanda M A Boer, Myrna M T de Rooij, Gerard H Koppelman, Warner van Kersen, et al. (+4) Judith M Vonk, Roel Vermeulen, Ulrike Gehring, Anke Huss |
| 37 |
[GO] |
2023―Nov―08 |
Double-Negative Results Matter: A Reevaluation of Sensitivities for Detecting SARS-CoV-2 Infection Using Saliva Versus Nasopharyngeal Swabs |
Zheng Wang, Yu-Lun Liu, Yong Chen, Lianne Siegel, Joseph C Cappelleri, Haitao Chu |
| 38 |
[GO] |
2023―Oct―12 |
Clinical Features and Outcomes of Hospitalized Adult Patients with Breakthrough COVID-19 Infections: A Propensity Score-Matched Observational Study |
Jianli Niu, Shenae Samuels, Candice Sareli, Daniel Mayer, Alvaro Visbal, Aharon E Sareli |
| 39 |
[GO] |
2023―Sep―16 |
Demographic and Geographic Characterization of Excess Mortality During the COVID-19 Pandemic in Baltimore City, MD, March 2020 - March 2021 |
Kyle T Aune, Kyra H Grantz, Neia Prata Menezes, Katherine O Robsky, Emily S Gurley, Melissa A Marx, Darcy F Phelan-Emrick |
| 40 |
[GO] |
2023―Sep―01 |
Life Expectancy Changes During the COVID-19 Pandemic, 2019-2021: Highly Racialized Deaths in Young and Middle Adulthood Distinguish the United States Among High-Income Countries |
Ryan K Masters, Laudan Y Aron, Steven H Woolf |
| 41 |
[GO] |
2023―Sep―01 |
Challenges in Estimating Effectiveness of 2 Doses of COVID-19 Vaccines Beyond 6 Months in England |
Elsie M F Horne, William J Hulme, Ruth H Keogh, Tom M Palmer, Elizabeth J Williamson, Edward P K Parker, et al. (+12) Venexia M Walker, Rochelle Knight, Yinghui Wie, Kurt Taylor, Louis Fisher, Jessica Morley, Amir Mehrkar, Iain Dillingham, Sebastian Bacon, Ben Goldacre, Jonathan A C Sterne, The OpenSAFELY Collaborative |
| 42 |
[GO] |
2023―Aug―22 |
Risk factors for community and intra-household transmission of SARS-Cov-2: a modelling study in the French national population-based EpiCov cohort |
Sophie Novelli, Lulla Opatowski, Carmelite Manto, Delphine Rahib, Xavier de Lamballerie, Josiane Warszawski, et al. (+2) Laurence Meyer, on behalf of the EpiCov study group |
| 43 |
[GO] |
2023―Aug―08 |
Population Attributable Fraction of Non-Vaccination of COVID-19 Due to Vaccine Hesitancy, United States, 2021 |
Kimberly H Nguyen, Ruitong Zhao, Siyu Chen, Akhil K Vaish, Robert A Bednarczyk, Lavanya Vasudevan |
| 44 |
[GO] |
2023―May―31 |
Impact of allocation concealment and blinding in trials addressing treatments for COVID-19: A methods study |
Dena Zeraatkar, Tyler Pitre, Juan Pablo Diaz-Martinez, Derek Chu, Bram Rochwerg, Francois Lamontagne, et al. (+4) Elena Kum, Anila Qasim, Jessica J Batoszko, Romina Brignardello-Peterson |
| 45 |
[GO] |
2023―May―24 |
The Evolution of Excess Deaths in the United States During the First Two Years of the COVID-19 Pandemic |
Christopher J Ruhm |
| 46 |
[GO] |
2023―May―16 |
Use of community SARS-CoV2 case counts and instantaneous reproductive number to predict short-term COVID-19 hospital admission volumes |
Michael I Oppenheim, Juan Rada, Abraham Saraya, Kevin R Bock, John D’Angelo, Bruce Farber |
| 47 |
[GO] |
2023―Apr―29 |
SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic Recency |
Saki Takahashi, Michael J Peluso, Jill Hakim, Keirstinne Turcios, Owen Janson, Isobel Routledge, et al. (+9) Michael P Busch, Rebecca Hoh, Viva Tai, J Daniel Kelly, Jeffrey N Martin, Steven G Deeks, Timothy J Henrich, Bryan Greenhouse, Isabel Rodríguez-Barraquer |
| 48 |
[GO] |
2023―Apr―21 |
A mixture model to estimate SARS-CoV-2 seroprevalence in Chennai, India |
Matt D T Hitchings, Eshan U Patel, Rifa Khan, Aylur K Srikrishnan, Mark Anderson, K S Kumar, et al. (+7) Amy P Wesolowski, Syed H Iqbal, Mary A Rodgers, Shruti H Mehta, Gavin Cloherty, Derek A T Cummings, Sunil S Solomon |
| 49 |
[GO] |
2023―Apr―19 |
Long COVID Incidence in a Large US Ambulatory Electronic Health Record System |
Robert Sedgley, Jessamine Winer-Jones, Machaon Bonafede |
| 50 |
[GO] |
2023―Apr―13 |
Behavioral and personal characteristics associated with risk of SARS-CoV-2 infection in a Spanish university cohort |
Fares Amer, Mario Gil-Conesa, Silvia Carlos, Arturo H Ariño, Francisco Carmona-Torre, Miguel A Martínez-González, Alejandro Fernandez-Montero |
| 51 |
[GO] |
2023―Apr―07 |
Standardized cumulative metrics of excess mortality to monitor health system resilience throughout COVID-19 and other respiratory virus resurgences |
Gkikas Magiorkinis |
| 52 |
[GO] |
2023―Mar―24 |
Comment on Risk and benefit of mRNA COVID-19 vaccines for Omicron variant |
Amnuay Kleebayoon, Viroj Wiwanitkit |
| 53 |
[GO] |
2023―Mar―17 |
COVID-19 Vaccine Safety Surveillance in Early Pregnancy in the United States: Design Factors Affecting the Association Between Vaccine and Spontaneous Abortion |
Gabriela Vazquez-Benitez, Jacob L Haapala, Heather S Lipkind, Malini B DeSilva, Jingyi Zhu, Matthew F Daley, et al. (+12) Darios Getahun, Nicola P Klein, Kimberly K Vesco, Stephanie A Irving, Jennifer C Nelson, Joshua T B Williams, Simon J Hambidge, James Donahue, Candace C Fuller, Eric S Weintraub, Christine Olson, Elyse O Kharbanda |
| 54 |
[GO] |
2023―Mar―15 |
Risk and benefit of mRNA COVID-19 vaccines for Omicron variant by age, sex and presence of comorbidity: a quality-adjusted life years analysis |
Taito Kitano, David A Thompson, Lilly Engineer, Matthew Dudley, Daniel A Salmon |
| 55 |
[GO] |
2023―Mar―08 |
Response to “Commentary: Does Covid-19 vaccination disturb menstrual cycling?” by Clarice Weinberg, PhD |
Emily R Boniface, Alison B Edelman, Blair G Darney |
| 56 |
[GO] |
2023―Mar―08 |
Retrospective, Observational Studies for Estimating Vaccine Effects on the Secondary Attack Rate of SARS-CoV-2 |
Marlena S Bannick, Fei Gao, Elizabeth R Brown, Holly E Janes |
| 57 |
[GO] |
2023―Feb―24 |
Modern epidemiology confronts COVID-19: reflections from psychiatric epidemiology |
Gonzalo Martínez-Alés, Katherine Keyes |
| 58 |
[GO] |
2023―Feb―17 |
Design and Implementation of the All of Us Research Program COVID-19 Participant Experience (COPE) Survey |
Claire E Schulkey, Tamara R Litwin, Genevieve Ellsworth, Heather Sansbury, Brian K Ahmedani, Karmel W Choi, et al. (+20) Robert Cronin, Yasmin Kloth, Alan W Ashbeck, Scott Sutherland, Brandy Mapes, Mark Begale, Geeta Bhat, Paula King, Kayla Marginean, Keri Ann Wolfe, Aymone Kouame, Carmina Raquel, Francis Ratsimbazafy, Zach Bornemeier, Kyle Neumeier, Rubin Baskir, Kelly A Gebo, Joshua Denny, Jordan W Smoller, Holly A Garriock |
| 59 |
[GO] |
2023―Feb―17 |
Commentary: Does Covid-19 vaccination disturb menstrual cycling? |
Clarice Weinberg |
| 60 |
[GO] |
2023―Jan―27 |
Waning of two-dose BNT162b2 and mRNA-1273 vaccine effectiveness against symptomatic SARS-CoV-2 infection is robust to depletion-of-susceptibles bias |
Kristin L Andrejko, Jake M Pry, Jennifer F Myers, Megha Mehrotra, Katherine Lamba, Esther Lim, et al. (+7) Nozomi Fukui, Jennifer L DeGuzman, John Openshaw, James Watt, Seema Jain, Joseph A Lewnard, on behalf of the California COVID-19 Case-Control Study Team |
| 61 |
[GO] |
2023―Jan―27 |
Undiagnosed and Undertreated: The Suffocating Consequences of Racially-Biased Medical Devices During the COVID-19 Pandemic |
Marie V Plaisime |
| 62 |
[GO] |
2023―Jan―12 |
Everyone Wins: Vaccine Lotteries Can Cost-Effectively Increase COVID-19 Booster Vaccination Rates |
Zoë M McLaren |
| 63 |
[GO] |
2023―Jan―10 |
A demonstration of Modified Treatment Policies to evaluate shifts in mobility and COVID-19 case rates in U.S. counties |
Joshua R Nugent, Laura B Balzer |
| 64 |
[GO] |
2023―Jan―05 |
Some Social Epidemiologic Lessons from the COVID-19 Pandemic |
Alina S Schnake-Mahl, Usama Bilal |
| 65 |
[GO] |
2022―Nov―24 |
Current Challenges With the Use of Test-Negative Designs for Modeling COVID-19 Vaccination and Outcomes |
Xu Shi, Kendrick Qijun Li, Bhramar Mukherjee |
| 66 |
[GO] |
2022―Nov―02 |
Performance of Existing and Novel Symptom- and Antigen Testing-Based COVID-19 Case Definitions in a Community Setting |
Scott Lee, Olivia Almendares, Jessica Prince-Guerra, Mark Anderson, Charles M Heilig, Jacqueline E Tate, Hannah L Kirking |
| 67 |
[GO] |
2022―Oct―10 |
Optimizing SARS-CoV-2 Pooled Testing Strategies Through Differentiated Pooling for Distinct Groups |
Lindsey M Filiatreau, Paul N Zivich, Jessie K Edwards, Grace E Mulholland, Ryan Max, Daniel Westreich |
| 68 |
[GO] |
2022―Oct―07 |
The Impact of COVID-19 on the All of Us Research Program |
Sarra L Hedden, James McClain, Allison Mandich, Rubin Baskir, Mark S Caulder, Joshua C Denny, et al. (+8) Michelle R J Hamlet, Irene Prabhu Das, Nicole Mc Neil Ford, Maria Lopez-Class, Ahmed Elmi, Roshedah Wallace, Amantha Linkie, Holly A Garriock |
| 69 |
[GO] |
2022―Oct―05 |
CORRECTION TO: IMPACT OF BNT162B2 VACCINATION AND ISOLATION ON SARS-COV-2 TRANSMISSION IN ISRAELI HOUSEHOLDS: AN OBSERVATIONAL STUDY |
|
| 70 |
[GO] |
2022―Sep―29 |
Racial Disparities in Pulse Oximeter Device Inaccuracy and Estimated Clinical Impact on COVID-19 Treatment Course |
Sylvia E K Sudat, Paul Wesson, Kim F Rhoads, Stephanie Brown, Noha Aboelata, Alice R Pressman, et al. (+2) Aravind Mani, Kristen M J Azar |
| 71 |
[GO] |
2022―Sep―06 |
Estimating the Effectiveness of First Dose of COVID-19 Vaccine Against Mortality in England: A Quasi-Experimental Study |
Charlotte Bermingham, Jasper Morgan, Daniel Ayoubkhani, Myer Glickman, Nazrul Islam, Aziz Sheikh, et al. (+3) Jonathan Sterne, A Sarah Walker, Vahé Nafilyan |
| 72 |
[GO] |
2022―Aug―02 |
Long-Term Fine Particulate Matter Concentrations and SARS-CoV-2 Prevalence: Differential Relationships by Socioeconomic Status Among Pregnant Individuals in New York City |
Joan A Casey, Marianthi-Anna Kioumourtzoglou, Elizabeth L Ogburn, Alexander Melamed, Jeffrey Shaman, Sasikiran Kandula, et al. (+4) Andreas Neophytou, Kristin C Darwin, Jeanne S Sheffield, Cynthia Gyamfi-Bannerman |
| 73 |
[GO] |
2022―Jul―25 |
Predicting need for escalation of care or death from repeated daily clinical observations and laboratory results in patients with SARS-CoV-2 |
Colin J Crooks, Joe West, Andrew Fogarty, Joanne R Morling, Matthew J Grainge, Sherif Gonem, et al. (+7) Mark Simmonds, Andrea Race, Irene Juurlink, Steve Briggs, Simon Cruickshank, Susan Hammond-Pears, Timothy R Card |
| 74 |
[GO] |
2022―Jun―29 |
Data-Driven Commentary on SARS-CoV-2 Infection, Vaccination, and Fertility |
Sigal Klipstein, Jodie A Dionne, Eve C Feinberg, Jennifer F Kawwass, Samantha M Pfeifer, Peter N Schlegel, Catherine Racowsky |
| 75 |
[GO] |
2022―Jun―28 |
Patterned Outcomes, Unpatterned Counterfactuals, and Spurious Results: Perinatal Health Outcomes Following COVID-19 |
Alison Gemmill, Joan A Casey, Claire E Margerison, Jennifer Zeitlin, Ralph Catalano, Tim A Bruckner |
| 76 |
[GO] |
2022―Apr―21 |
Anticipating Racial/Ethnic Mortality Displacement From COVID-19 |
Stephen M Kissler, Yonatan H Grad |
| 77 |
[GO] |
2022―Mar―27 |
Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel |
Yair Goldberg, Micha Mandel, Yonatan Woodbridge, Ronen Fluss, Ilya Novikov, Rami Yaari, et al. (+3) Arnona Ziv, Laurence Freedman, Amit Huppert |
| 78 |
[GO] |
2022―Mar―04 |
Factors associated with SARS-CoV-2 transmission in setting of high COVID-19 vaccination coverage: a case-control study |
Michael J A Reid, Tommaso C Bulfone, Cinthia Blat, Yea-Hung Chen, George W Rutherford, Susan Philip, et al. (+6) Luis Gutierrez-Mock, Andrea Nickerson, Laura Buback, Susie Welty, Arthur Reingold, Wayne T A Enanoria |
| 79 |
[GO] |
2022―Mar―01 |
Impact of BNT162b2 vaccination and isolation on SARS-CoV-2 transmission in Israeli households: an observational study |
Maylis Layan, Mayan Gilboa, Tal Gonen, Miki Goldenfeld, Lilac Meltzer, Alessio Andronico, et al. (+3) Nathanaël Hozé, Simon Cauchemez, Gili Regev-Yochay |
| 80 |
[GO] |
2022―Feb―14 |
Factors Associated with Willingness to Receive a COVID-19 Vaccine among 23,819 Adults Aged 50 years and Older: An Analysis of the Canadian Longitudinal Study on Aging |
Nicole E Basta, Nazmul Sohel, Giorgia Sulis, Christina Wolfson, Geva Maimon, Lauren E Griffith, et al. (+5) Susan Kirkland, Jacqueline M McMillan, Mary Thompson, Parminder Raina, on behalf of the Canadian Longitudinal Study on Aging (C L S A) Team |
| 81 |
[GO] |
2022―Jan―25 |
Identifying and alleviating bias due to differential depletion of susceptible people in post-marketing evaluations of COVID-19 vaccines |
Rebecca Kahn, Stephanie J Schrag, Jennifer R Verani, Marc Lipsitch |
| 82 |
[GO] |
2022―Jan―24 |
What has the pandemic revealed about the shortcomings of modern epidemiology? What can we fix or do better? |
Michelle C Dimitris, Sandro Galea, Julia L Marcus, An Pan, Beate Sander, Robert W Platt |
| 83 |
[GO] |
2022―Jan―12 |
Effectiveness of Localized Lockdowns in the COVID-19 Pandemic |
Yige Li, Eduardo A Undurraga, José R Zubizarreta |
| 84 |
[GO] |
2021―Oct―05 |
Choice of Outcome in COVID-19 Studies and Implications for Policy: Mortality and Fatality |
Daniel Westreich, Jessie K Edwards, Peter W G Tennant, Eleanor J Murray, Maarten van Smeden |
| 85 |
[GO] |
2021―Sep―29 |
Explaining ethnic differentials in COVID-19 mortality: cohort study |
G David Batty, Bamba Gaye, Catharine R Gale, Mark Hamer, Camille Lassale |
| 86 |
[GO] |
2021―Jun―30 |
Disparities among Racially/Ethnically Marginalized Groups in the COVID-19 Pandemic Persist Regardless of Statewide Shelter-in-Place Policies: An Analysis from Northern California |
Kristen M J Azar, Stephen H Lockhart, Zijun Shen, Robert Romanelli, Stephanie Brown, Kelly Smits, Alice R Pressman |
| 87 |
[GO] |
2021―Jun―21 |
Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans |
Hanna Gerlovin, Daniel C Posner, Yuk-Lam Ho, Christopher T Rentsch, Janet P Tate, Joseph T King Jr, et al. (+15) Katherine E Kurgansky, Ioana Danciu, Lauren Costa, Franciel A Linares, Ian D Goethert, Daniel A Jacobson, Matthew S Freiberg, Edmon Begoli, Sumitra Muralidhar, Rachel B Ramoni, Georgia Tourassi, J Michael Gaziano, Amy C Justice, David R Gagnon, Kelly Cho |
| 88 |
[GO] |
2021―Mar―09 |
Disparities in COVID-19 deaths by country of birth in Stockholm, Sweden: A total population based cohort study |
Mikael Rostila, Agneta Cederström, Matthew Wallace, Maria Brandén, Bo Malmberg, Gunnar Andersson |
| 89 |
[GO] |
2021―Mar―09 |
Person, Place, Time and COVID-19 Inequities |
Alina S Schnake-Mahl, Usama Bilal |
| 90 |
[GO] |
2021―Mar―09 |
A Geography of Risk: Structural Racism and COVID-19 Mortality in the United States |
Lauren C Zalla, Chantel L Martin, Jessie K Edwards, Danielle R Gartner, Grace A Noppert |
| 91 |
[GO] |
2021―Feb―10 |
The Usefulness Of SARS-CoV-2 Test-Positive Proportion As A Surveillance Tool |
Matt D T Hitchings, Natalie E Dean, Bernardo Garcia-Carreras, Thomas J Hladish, Angkana T Huang, Bingyi Yang, Derek A T Cummings |
| 92 |
[GO] |
2021―Feb―05 |
The Impact of Epidemiology on Prenatal and Fertility Care during the COVID-19 Pandemic |
Jodie Dionne-Odom, Sigal Klipstein |
| 93 |
[GO] |
2021―Feb―05 |
Biases in evaluating the safety and effectiveness of drugs for covid-19: designing real-world evidence studies |
Christel Renoux, Laurent Azoulay, Samy Suissa |
| 94 |
[GO] |
2020―Dec―21 |
Teaching Epidemiology Online (Pandemic Edition) |
Hailey R Banack, Catherine R Lesko, Brian C Whitcomb, Lindsay C Kobayashi |
| 95 |
[GO] |
2020―Jul―23 |
The Logistics of “Making the Best Use of Test Kits for COVID-19”: Testing More to Test Less |
P Saha-Chaudhuri |
| 96 |
[GO] |
2020―Jul―18 |
What Now? Epidemiology in the Wake of a Pandemic |
Jessie K Edwards, Justin Lessler |
| 97 |
[GO] |
2020―Jun―29 |
Racial Capitalism within Public Health: How Occupational Settings Drive COVID-19 Disparities |
Elizabeth S McClure, Pavithra Vasudevan, Zinzi Bailey, Snehal Patel, Whitney R Robinson |
| 98 |
[GO] |
2020―May―05 |
Editorial: Making the Best Use of Test Kits for COVID-19 |
Clarice R Weinberg |
| 99 |
[GO] |
2020―Jan―08 |
L2: Cross Border Epidemiology: When Pandemic Influenza Comes to the Northwest, 2004 - 2005 |
E Sergienko, P Cox, J Hofmann, D Patrick |
|
